Email ID
Password
Scrip   
Abbott pays $170 million for PanGenetics' anti-NGF antibody
13 November 2009
Eleanor Malone

Abbott will pay $170 million up front to acquire a Phase I nerve growth factor (NGF) antibody from the Dutch antibody company PanGenetics. The deal, which is expected to close by the end of this year, also allows for a further $20 million in future milestone payments to PanGenetics.

Abbott...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36